Enhanced breast cancer screening for high-risk women
Part of Cancer, Skin clinical trials.
This study tests a more thorough breast cancer screening program using MRI and other imaging for women at high risk. It aims to detect cancer earlier, which may improve treatment options and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 25 or older.
- You have a known genetic mutation that increases breast cancer risk (like BRCA1, BRCA2, or others), OR a calculated lifetime risk of 30% or higher, OR you were in the WISDOM study and were recommended for MRI every 6 months, OR you had chest radiation before age 35.
- You have no active cancer treatment currently (but you may be taking preventive medications like tamoxifen).
- You are not pregnant, and you don't have any metal implants (like a pacemaker) that could interfere with an MRI.
- You have not had breast surgery within the last two weeks.
- You are willing to travel to the University of Chicago for imaging and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study compares a newer breast cancer risk approach with standard guidelines, and then uses a special MRI to look for cancer early. If the MRI looks concerning, doctors will confirm the finding with a biopsy.
This study is testing whether adding an MRI to your regular mammogram can help find any new breast cancers earlier. It is for women who have had breast cancer before and still have dense breast tissue, making mammograms harder to read.
This study uses a breast MRI scan to look at suspicious areas in the breast. It may help doctors better tell which breast changes need closer follow-up like a biopsy.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
This study tests selected treatment decisions for women with early-stage breast cancer that has certain lab test results. It may help researchers better match care using MRI and tumor marker information.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.